Thursday 4 October 2018, 2.00PM to - 3.15pm
Speaker(s): Josh Carlson, Associate Professor, School of Pharmacy, University of Washington
Abstract: HTA in the United States has historically focused on the clinical impact of new interventions. However, recent activities have increased the production and use of value assessments and cost-effectiveness analyses in healthcare decision making. In particular, the Institute for Clinical and Economic Reviews (ICER), modeled in part on NICE, has emerged as an important player in the U.S. healthcare landscape. Dr. Carlson will provide an overview of HTA in the U.S. and lead a discussion about ICER in terms of its structure, processes for generating HTA reports, impact, and ongoing evolution.
Location: ARRC Auditorium A/RC/014
Who to contact
For more information on these seminars, contact:
Adrian Villasenor
Adrian Villasenor-Lopez
Dacheng Huo
Dacheng Huo
If you are not a member of University of York staff and are interested in attending the seminar, please contact Adrian Villasenor-Lopez or Dacheng Huo so that we can ensure we have sufficient space
CHE Seminar Programme
- Monday 21 January
Professor Rachel Baker, Yunus Centre for Social Business and Health- Thursday 7 February
Professor Philip Clarke, The Universities of Melbourne and Oxford- Thursday 7 March
Professor Sonia Bhalhotra, University of Essex- Thursday 4 April
Eugenio Zucchelli, Lancaster University- Monday 13 May
Davide Rasella, Fiocruz Brazil- Thursday 4 July
Stephanie von Hinke Kessler Scholder, Bristol University- Thursday 5 September
Jose-Luis Fernandez, LSE- Thursday 3 October
Soren Rud Kristensen, Imperial- Thursday 7 November
Linda Davies, Manchester University- Wednesday 5 December
Mandy Ryan, HERU, University of Aberdeen